Camber Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-500,000
| Closed | -$12.6M | – | 48 |
|
|
2022
Q3 | $12.6M | Sell |
500,000
-1,000,000
| -67% | -$25.1M | 0.38% | 40 |
|
|
2022
Q2 | $45.6M | Hold |
1,500,000
| – | – | 1.98% | 17 |
|
|
2022
Q1 | $49.1M | Buy |
+1,500,000
| New | +$49.1M | 1.78% | 20 |
|
|
2021
Q4 | – | Sell |
-685,000
| Closed | -$68.9M | – | 41 |
|
|
2021
Q3 | $68.9M | Buy |
685,000
+220,000
| +47% | +$22.1M | 2.12% | 20 |
|
|
2021
Q2 | $65.8M | Buy |
465,000
+65,000
| +16% | +$9.2M | 2.22% | 18 |
|
|
2021
Q1 | $39.9M | Buy |
+400,000
| New | +$39.9M | 1.37% | 24 |
|